Commercial specialty medication research: 2016 benchmark projections
06 January 2015
Specialty costs are expected to continue to rise and to become a more significant proportion of pharmacy and overall healthcare expenditures. According to this study, total medication costs, including those adjudicated under both the medical and pharmacy benefits, are expected to account for nearly 30% of total healthcare claim costs in 2016.
About the Author(s)
Commercial specialty medication research: 2016 benchmark projections
This study provides specialty medication claim cost benchmarks to illustrate the magnitude and distribution of specialty medication costs adjudicated under the pharmacy and medical benefit.
Justin Harris, Katherine Holcomb